Profile
ARTL VRTX ALNY REGN ARGX SGEN
Company Name Artelo Biosciences, Inc. Vertex Pharmaceuticals Incorporated Alnylam Pharmaceuticals, Inc. Regeneron Pharmaceuticals, Inc. argenx SE Seagen Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology
Market Cap $3.74M $101.65B $61.42B $57.97B $46.27B $43.15B
Employees 0.01K 6.10K 2.23K 15.16K 1.60K 3.26K
CEO Gregory D. Gorgas Reshma Kewalramani FASN, Yvonne L. Greenstreet Leonard S. Schleifer Timothy Van Hauwermeiren EMBA, David R. Epstein
Ratings
ARTL VRTX ALNY REGN ARGX SGEN
Quant Rating Score 2 4 1 4 4 3
Quant Rating Sell Buy Strong Sell Buy Buy Neutral
Trading
ARTL VRTX ALNY REGN ARGX SGEN
Last Close $4.91 $387.15 $451.725 $585.5 $734.35 $228.74
High 52 $28.25 $516.74 $482.13 $1150.19 $768 $228.74
Low 52 $0.82 $366.54 $224.58 $482.92 $519.76 $228.74
Price vs. 52 Week High -82.62 % -25.08 % -6.31 % -49.1 % -4.38 % 0 %
Price vs. 52 Week Low 498.78 % 5.62 % 101.14 % 21.24 % 41.29 % 0 %
Total Return
ARTL VRTX ALNY REGN ARGX SGEN
1 Month Return -49.69 % -0.7 % -1.13 % 2.04 % 11.04 % 0 %
3 Month Return -18.17 % -13.66 % 44.64 % 14 % 36.52 % 0 %
6 Month Return 433.41 % -24.42 % 84.91 % -11.98 % 20.15 % 0 %
9 Month Return 381.42 % -13.49 % 89.86 % -18.07 % 17.65 % 0 %
YTD Return 363.21 % -3.86 % 91.97 % -17.8 % 19.41 % 0 %
1 Year Return 346.36 % -18.35 % 65.38 % -48.59 % 38.8 % 0 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
ARTL VRTX ALNY REGN ARGX SGEN
Dividend Yield Percentage (TTM) - - - 0.47 % - -
Dividend Paid and Capex Coverage Ration (TTM) - 11.09 % -0.43 % 4.37 % -44.32 % -5.87 %
Dividend Per Share (TTM) - - - 2.64 % - -
Payout Ratio (TTM) - - - 4.18 % - -
Growth
ARTL VRTX ALNY REGN ARGX SGEN
Asset Growth -63.98 % -0.87 %
Gross Profit Growth - 10.25 %
Revenue Growth - 11.66 %
Revenue 3 Year - 45.6 %
Revenue 5 Year - 163.93 %
Revenue 10 Year - 1632.15 %
EBIT Growth -5.78 % -93.69 %
Net Income Growth -5.78 % -114.8 %
Net Income 3 Yeari Growth Per Share 85.73 % -122.89 %
Net Income 5 Yeari Growth Per Share 97.3 % -145.38 %
Net Income 10 Yeari Growth Per Share -112.25 % 33.84 %
Operating Income Growth -1.79 % -106.08 %
Operating Cash Flow Growth (CFG) -1.74 % -113.93 %
Operating 3 Year CFG 84.73 % -118.65 %
Operating 5 Year CFG 97.55 % -131.3 %
Operating 10 Year CFG -103.6 % 12.43 %
EPS Growth 2.87 % -114.8 %
EPS Diluted Growth 2.87 % -114.97 %
Book Value Per Share -77.67 % -6.59 %
Share Holder 3 Year Equity Growth Per Share -97.84 % 62.6 %
Share Holder 5 Year Equity Growth Per Share -99.06 % 168.85 %
Share Holder 10 Year Equity Growth Per Share -38.48 % 1292.6 %
Dividend Per Share Growth - -
Dividend 3 Year Growth Per Share - -
Dividend 5 Year Growth Per Share - -
Dividend 10 Year Growth Per Share - -
Debt Growth 352.17 % 116.42 %
Free Cash Flow Growth -1.74 % -124.1 %
Updated On 31 Dec 2024 31 Dec 2024
Profitability
ARTL VRTX ALNY REGN ARGX SGEN
Gross Profit Margin TTM - 86.11 % 83.64 % 81.98 % 65.32 % 79.1 %
Return on Assets TTM -241.06 % 15.13 % -6.99 % 11.67 % 15.06 % -16.61 %
Return on Equity TTM -496.36 % 22.14 % -274.21 % 15.11 % 18.96 % -20.8 %
Return on Capital Employed TTM 777.56 % 19.72 % -5.52 % 11.45 % 5.04 % -21.46 %
Net Income Per EBT TTM 100 % 83.16 % 84.06 % 91.46 % 237.3 % 101.33 %
EBT Per Ebit TTM 99.69 % 111.48 % 210.66 % 123.23 % 147.38 % 98.26 %
EBIT Per Revenue TTM - 34.36 % -7.32 % 27.83 % 13.47 % -31.24 %
Cash Flow To Debt Ratio TTM -739.51 % 251.83 % -1.2 % 175.35 % -175.92 % -1043.73 %
Receivables Turnover TTM - 6.03 4.34 2.53 1.91 3.91
Payables Turnover TTM - 0.43 3.93 3.54 0.88 1.97
Inventory Turnover TTM - 1.06 5.62 0.8 2.21 0.96
Fixed Asset Turnover TTM - 431.08 % 355.68 % 293.64 % 5009.77 % 665.41 %
Asset Turnover TTM - 47.51 % 53.92 % 37.19 % 31.97 % 53.41 %
Operating Cash Flow Per Share TTM -11.54 14.98 -0.12 45.13 -1.07 -2.46
Free Cash Flow Per Share TTM -11.54 13.63 -0.4 36.58 -1.09 -2.88
Cash Per Share TTM 359.93 % 3036 % 2203.63 % 7107.14 % 5536.58 % 939.52 %
Operating Cash Flow Sales Ratio TTM - 33.68 % -0.63 % 33.37 % -3.31 % -23.12 %
Free Cash Flow Operating Cash Flow Ratio TTM 100 % 90.99 % 335.21 % 81.05 % 102.26 % 117.04 %
Cash Flow Coverage Ratios TTM -739.51 % 251.83 % -1.2 % 175.35 % -175.92 % -1043.73 %
Price To Free Cash Flows Ratio TTM -0.56 29.05 -1179.18 15.08 -596.18 -81.26
Price To Operating Cash Flows Ratio TTM -0.46 26.46 -3910.39 12.33 -706.75 -93.1
Price Cash Flow Ratio TTM -0.46 26.46 -3910.39 12.33 -706.75 -93.1
Income Statement (TTM)
ARTL VRTX ALNY REGN ARGX SGEN
Revenue $0B $11.02B $2.25B $14.2B $2.19B $1.96B
Gross Profit $0B $9.49B $1.92B $11.75B $1.96B $1.55B
Gross Profit Ratio 0% 86.11% 85.62% 82.74% 89.62% 79.1%
EBITDA $-0.01B $0.49B $-0.18B $5.32B $0.11B $-0.62B
Net Income $-0.01B $-0.54B $-0.28B $4.41B $0.83B $-0.61B
EPS Diluted -3.05 -2.08 -2.16 38.34 12.78 -3.3
Balance Sheet (MRQ)
ARTL VRTX ALNY REGN ARGX SGEN
Long Term Debt $0B $1.66B $1.25B $2.7B $0.03B $0.04B
Total Liabilities $0B $6.12B $4.17B $8.41B $0.7B $0.87B
Total Equity $0B $16.41B $0.07B $29.35B $5.5B $2.8B
Total Investments $0B $6.65B $1.73B $15.42B $1.93B $1.42B
Total Debt $0B $1.75B $1.3B $2.7B $0.04B $0.04B
Total Assets $0B $22.53B $4.24B $37.76B $6.2B $3.67B
Cash Flow Statement (TTM)
ARTL VRTX ALNY REGN ARGX SGEN
Net Income $-0.01B $-0.54B $-0.28B $4.41B $0.83B $-0.61B
Inventory $0B $-0.52B $0.01B $-0.62B $-0.1B $-0.23B
Dividends Paid $0B $0B $0B $0B $0B $0B
Operating Cash Flow $-0.01B $-0.49B $-0.01B $4.42B $-0.08B $-0.45B
Capital Expenditure $0B $-0.3B $-0.03B $-0.76B $-0.07B $-0.08B
Related Stocks
Ticker Name Price
AADI Aadi Bioscience, Inc. 2.05
AAPG 39.38
AARD Aardvark Therapeutics, Inc. Common Stock 11.815
ABCL AbCellera Biologics Inc. 4.7335
ABCM Abcam plc 23.99
ABEO Abeona Therapeutics Inc. 5.685
ABIO ARCA biopharma, Inc. 28.8
ABOS Acumen Pharmaceuticals, Inc. 1.3011
ABPWW 0.046281
ABSI Absci Corporation 2.6605
ABUS Arbutus Biopharma Corporation 4.39
ABVC ABVC BioPharma, Inc. 2.76
ABVX Abivax SA American Depositary Shares 83.38
ACAD ACADIA Pharmaceuticals Inc. 24.515
ACER Acer Therapeutics Inc. 0.6601
ACET Adicet Bio, Inc. 0.8094
ACGN Aceragen, Inc. 0.3849
ACHL Achilles Therapeutics plc 1.48
ACHV Achieve Life Sciences, Inc. 2.945
ACIU AC Immune SA 2.4679
ETFs With Exposure to ARTL
Ticker ETF Name Weight Percentage Price
VXF Vanguard Extended Market Index Fund 0.00005 212.87
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0.00005 158.73
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0.00005 158.74
VEMPX Vanguard Extended Market Index InstlPlus 0.00005 391.73
Unlock